Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2016 1
2017 1
2018 1
2019 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
A two-gene methylation signature for the diagnosis of bladder cancer in urine.
Bosschieter J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, Segerink LI, Vis AN, Wilting SM, Lissenberg-Witte BI, A van Moorselaar RJ, Steenbergen RD. Bosschieter J, et al. Among authors: a van moorselaar rj. Epigenomics. 2019 Feb;11(3):337-347. doi: 10.2217/epi-2018-0094. Epub 2019 Feb 1. Epigenomics. 2019. PMID: 30706728
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX).
Bex A, van Thienen JV, Schrier M, Graafland N, Kuusk T, Hendricksen K, Lagerveld B, Zondervan P, van Moorselaar JA, Blank C, Wilgenhof S, Haanen J. Bex A, et al. Among authors: van moorselaar ja. Future Oncol. 2019 Jul;15(19):2203-2209. doi: 10.2217/fon-2019-0111. Epub 2019 Apr 26. Future Oncol. 2019. PMID: 31023100 Clinical Trial.
miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.
Bijnsdorp IV, Hodzic J, Lagerweij T, Westerman B, Krijgsman O, Broeke J, Verweij F, Nilsson RJ, Rozendaal L, van Beusechem VW, van Moorselaar JA, Wurdinger T, Geldof AA. Bijnsdorp IV, et al. Among authors: van moorselaar ja. Oncotarget. 2016 Mar 29;7(13):16676-87. doi: 10.18632/oncotarget.7572. Oncotarget. 2016. PMID: 26918338 Free PMC article.
Effectiveness, cost-utility and implementation of a decision aid for patients with localised prostate cancer and their partners: study protocol of a stepped-wedge cluster randomised controlled trial.
Al-Itejawi HHM, van Uden-Kraan CF, van de Ven PM, Coupé VMH, Vis AN, Nieuwenhuijzen JA, van Moorselaar JA, Verdonck-de Leeuw IM. Al-Itejawi HHM, et al. Among authors: van moorselaar ja. BMJ Open. 2017 Sep 15;7(9):e015154. doi: 10.1136/bmjopen-2016-015154. BMJ Open. 2017. PMID: 28918408 Free PMC article. Clinical Trial.
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi).
Coelingh Bennink HJT, van Moorselaar JA, Crawford ED, Roos EPM, Somford DM, Roeleveld TA, de Haan TD, van Melick HHE, Reisman Y, Zimmerman Y, van Osta G, Krijgh J, Shore ND, Saad F, Schally AV, Debruyne FMJ. Coelingh Bennink HJT, et al. Among authors: van moorselaar ja. Eur Urol Open Sci. 2021 May 6;28:52-61. doi: 10.1016/j.euros.2021.04.005. eCollection 2021 Jun. Eur Urol Open Sci. 2021. PMID: 34337526 Free PMC article.